These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2039015)

  • 41. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strategies in antihypertensive therapy: implications of the kidney.
    Hollenberg NK
    Am J Med; 1986 Dec; 81(6A):15-9. PubMed ID: 2879443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Nakano N; Furukata S; Akashiba A; Minami J; Numabe A; Matsuoka H
    Clin Exp Hypertens; 2011; 33(6):366-72. PubMed ID: 21797795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis.
    Rakugi H; Ogihara T; Saruta T; Kawai T; Saito I; Teramukai S; Shimada K; Katayama S; Higaki J; Odawara M; Tanahashi N; Kimura G;
    J Hypertens; 2015 Oct; 33(10):2165-72. PubMed ID: 26066644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.
    Slagman MC; Waanders F; Vogt L; Damman K; Hemmelder M; Navis G; Laverman GD
    Nephrol Dial Transplant; 2012 Mar; 27(3):983-90. PubMed ID: 21862455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.
    Takenaka T; Uchida K; Kojima E; Gen S; Nodaira Y; Hoshi H; Kato N; Takane H; Ohno Y; Suzuki H
    Clin Exp Hypertens; 2011; 33(4):210-5. PubMed ID: 21699446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
    Konoshita T; Makino Y; Kimura T; Fujii M; Wakahara S; Arakawa K; Inoki I; Nakamura H; Miyamori I;
    J Hypertens; 2010 Oct; 28(10):2156-60. PubMed ID: 20625317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Place of calcium antagonists in antihypertensive therapy: introduction and round-table discussion.
    Bühler FR; Distler A; Laragh JH; Tourkantonis D; Valdes G; Weber MA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S929-32. PubMed ID: 6085379
    [No Abstract]   [Full Text] [Related]  

  • 51. Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.
    Fici F; Seravalle G; Koylan N; Nalbantgil I; Cagla N; Korkut Y; Quarti-Trevano F; Makel W; Grassi G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):289-296. PubMed ID: 28497339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
    Mizuno Y; Jacob RF; Mason RP
    Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-agent and combination therapy of essential hypertension.
    Weber MA; Drayer JI
    Am Heart J; 1984 Aug; 108(2):311-6. PubMed ID: 6147077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium metabolism, renin activity, and the antihypertensive effects of calcium channel blockade.
    Resnick L
    Am J Med; 1986 Dec; 81(6A):6-14. PubMed ID: 2432779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension.
    Tani S; Asayama K; Oiwa K; Harasawa S; Okubo K; Takahashi A; Tanabe A; Ohkubo T; Hirayama A; Kushiro T
    Hypertens Res; 2017 Oct; 40(10):892-898. PubMed ID: 28446804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Does the diuretic effect of calcium inhibitors play an important role in the hypertensive efficacy?].
    Maldonado Martin A; Gil Extremera B; Rubio Luengo MA
    Presse Med; 1995 Apr; 24(14):686-90. PubMed ID: 7770417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring　- The NOCTURNE Study.
    Kario K; Tomitani N; Kanegae H; Ishii H; Uchiyama K; Yamagiwa K; Shiraiwa T; Katsuya T; Yoshida T; Kanda K; Hasegawa S; Hoshide S
    Circ J; 2017 Jun; 81(7):948-957. PubMed ID: 28321001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of dietary modifications on the blood pressure response to antihypertensive medication.
    Huggins CE; Margerison C; Worsley A; Nowson CA
    Br J Nutr; 2011 Jan; 105(2):248-55. PubMed ID: 20807467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New therapeutic approaches to arterial hypertension].
    Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1330-4. PubMed ID: 6755692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy.
    Oshikawa J; Toya Y; Morita S; Taguri M; Hanaoka K; Hasegawa T; Kaizu K; Kamata K; Kobayashi S; Ohtake T; Sato T; Yasuda G; Kimura K; Umemura S
    Clin Exp Hypertens; 2014; 36(4):244-50. PubMed ID: 23848219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.